V019-7449 Screening compound: N-(4-{3-[(2,5-difluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl}phenyl)-2,6-difluorobenzamide

V019-7449 Screening compound: N-(4-{3-[(2,5-difluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl}phenyl)-2,6-difluorobenzamide
V019-7449 Screening compound: N-(4-{3-[(2,5-difluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl}phenyl)-2,6-difluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-7449
N-(4-{3-[(2,5-difluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl}phenyl)-2,6-difluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-7449

Molecular Formula

C24H19F4N3O2 (C24 H19 F4 N3 O2)

Compound Name

N-(4-{3-[(2,5-difluorophenyl)methyl]-2-oxo-1,3-diazinan-1-yl}phenyl)-2,6-difluorobenzamide

IUPAC name

N-(4-{3-[(25-difluorophenyl)methyl]-2-oxo-13-diazinan-1-yl}phenyl)-26-difluorobenzamide

SMILES

O=C(c(c(F)ccc1)c1F)Nc(cc1)ccc1N(CCCN1Cc(cc(cc2)F)c2F)C1=O

InChI

InChI=1S/C24H19F4N3O2/c25-16-5-10-19(26)15(13-16)14-30-11-2-12-31(24(30)33)18-8-6-17(7-9-18)29-23(32)22-20(27)3-1-4-21(22)28/h1,3-10,13H,2,11-12,14H2,(H,29,32)

InChI Key

PMSFRDKYXBLGEE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19929623

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.140

Distribution Coefficient, logD

5.132

Water Solubility, LogSw

-5.39

Polar Surface Area

42.888

Acid Dissociation Constant (pKa)

9.12

Base Dissociation Constant (pKb)

-0.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

V019-7449 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V019-7449 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-7449?
Check Price and Availability of V019-7449, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-7449 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-7449
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-7449
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-7449 available by request